在 2021, the global CTMS market stood at USD 944 百万. 复合年增长率为 11.6% 从 2022 到 2028, 预计价值将达到 ~USD 2,035 百万 2028, 根据 Gen Consulting 公司的一份新报告.

该行业报告提供了全球市场的市场预测, 接下来是对产品的详细分析, 部署方式, delivery mode, 和地区. The global market data on CTMS can be segmented by product: 服务, 软件. 据研究, the software segment had the largest share in the global CTMS market. CTMS market is further segmented by deployment mode: enterprise-based CTMS, site-based CTMS. 在 2021, the enterprise-based CTMS segment made up the largest share of revenue generated by the CTMS market. Based on delivery mode, the CTMS market is segmented into: cloud-based, 本地部署, web-based. 在这些当中, the web-based segment was accounted for the highest revenue generator in 2021. 根据地区, the CTMS market also can be divided into: 亚太地区, 欧洲, 北美, 世界其他地区 (排). 北美占据了最大的市场份额 2021.

The global CTMS market is highly competitive. Some of the leading companies operating in the market are Advarra Inc., ArisGlobal LLC, Clario (Bioclinica), DataTrak International Inc., IBM公司, Medidata Solutions Inc., 甲骨文公司, Paraxel International Corporation, Veeva Systems Inc.

以数据为中心的报告重点关注市场趋势, 各细分市场的现状和前景. 对主要地区进行全面的市场评估, 该报告对于现有参与者来说是宝贵的资产, 新进入者和未来投资者.

为什么购买这份报告?
– Get a detailed picture of the Global Clinical Trial Management Systems Market
– Identify segments/areas to invest in over the forecast period in the Global Clinical Trial Management Systems Market
– 了解竞争环境, 市场的领先参与者
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.